Post radiation mucosal ulcer risk after a hypofractionated stereotactic boost and conventional fractionated radiotherapy for oropharyngeal carcinoma.

Gerda M VerduijnSteven F PetitIris LauwersYvette van NordenNienke D SijtsemaAniel SewnaikHetty MastMarta CapalaRemi A NoutSarah BakerEsther van MeertenMischa S HoogemanAad van der LugtWilma D Heemsbergen

Published in: Acta oncologica (Stockholm, Sweden) (2022)

The risk of PRMU should be included in the cost benefit analysis when considering future research using a hypofractionated SBRT boost for OPSCC patients.

Keyphrases

radiation therapy
brain metastases
end stage renal disease
ejection fraction
newly diagnosed
radiation induced
chronic kidney disease
prognostic factors
small cell lung cancer
locally advanced
squamous cell carcinoma
patient reported outcomes
rectal cancer